Arcadia Biosciences Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
RKDA
- Investments
-
11
- Share Price
-
$0.19
- (As of Wednesday Closing)
Arcadia Biosciences General Information
Description
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Contact Information
Website
www.arcadiabio.comCorporate Office
- 5956 Sherry Lane
- Suite 2000
- Dallas, TX 75225
- United States
Corporate Office
- 5956 Sherry Lane
- Suite 2000
- Dallas, TX 75225
- United States
Arcadia Biosciences Timeline
Arcadia Biosciences Stock Performance
As of 18-Nov-2026, Arcadia Biosciences’s stock price is $0.19. Its current market cap is $1.14M with 6.07M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.19 | $0.19 | $0.11 - $3.87 | $1.14M | 6.07M | 2.3M | -$3.37 |
Arcadia Biosciences Financials Summary
As of 30-Sep-2026, Arcadia Biosciences has a trailing 12-month revenue of $5.06M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (3,503) | (3,166) | 1,712 | (11,092) |
| Revenue | 5,063 | 4,858 | 5,045 | 4,454 |
| EBITDA | (10,240) | (2,520) | (4,978) | (5,729) |
| Net Income | (10,232) | (2,339) | (7,038) | (13,981) |
| Total Assets | 4,716 | 6,546 | 13,517 | 19,705 |
| Total Debt | 0 | 0 | 155 | 1,007 |
Arcadia Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arcadia Biosciences Comparisons
Industry
Financing
Details
Arcadia Biosciences Competitors (3)
One of Arcadia Biosciences’s 3 competitors is Archer Daniels Midland, a Corporation company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Archer Daniels Midland | Corporation | Chicago, IL | ||||
| Keygene | Corporate Backed or Acquired | Wageningen, Netherlands | ||||
| Amyris (Biotechnology) | Private Equity-Backed | Emeryville, CA |
Arcadia Biosciences Patents
Arcadia Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022081864-A1 | Methods and compositions for increasing genetic diversity in cannabis plants | Inactive | 14-Oct-2020 | ||
| AU-2021336542-A1 | Methods of increasing fiber in a wheat grain | Inactive | 07-Sep-2020 | ||
| CA-3191219-A1 | Methods of increasing fiber in a wheat grain | Pending | 07-Sep-2020 | ||
| EP-4211250-A1 | Methods of increasing fiber in a wheat grain | Inactive | 07-Sep-2020 | ||
| US-20230413751-A1 | Methods of increasing fiber in a wheat grain | Inactive | 07-Sep-2020 | A01H1/103 |
Arcadia Biosciences Signals
Arcadia Biosciences Investments & Acquisitions (11)
Arcadia Biosciences’s most recent deal was a Seed Round with Fauna Bio for . The deal was made on 21-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fauna Bio | 21-Sep-2021 | Seed Round | Drug Discovery | ||
| Lief Holdings | 17-May-2021 | Merger/Acquisition | Personal Products | ||
| Saavy Naturals | 17-May-2021 | Merger/Acquisition | Personal Products | ||
| Zola (Beverages) | 17-May-2021 | Merger/Acquisition | Beverages | ||
| Vivagran | 19-Apr-2021 | Merger/Acquisition | Cultivation |
Arcadia Biosciences ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
39.09 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Food Products
Industry
of 508
Rank
Percentile
Soft Drinks
Subindustry
of 47
Rank
Percentile
Arcadia Biosciences Exits (3)
Arcadia Biosciences’s most recent exit was on 17-May-2021 from Saavy Naturals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Saavy Naturals | 17-May-2021 | Completed |
|
||
| Verdeca | 28-Feb-2012 | Completed |
|
||
| Bioceres Crop Solutions | Corporate | Completed |
|
Arcadia Biosciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Vivagran | Barcelona, Spain | 2006 | |
| Zola (Beverages) | Dallas, TX | 2001 |
Arcadia Biosciences FAQs
-
When was Arcadia Biosciences founded?
Arcadia Biosciences was founded in 2002.
-
Where is Arcadia Biosciences headquartered?
Arcadia Biosciences is headquartered in Dallas, TX.
-
What is the size of Arcadia Biosciences?
Arcadia Biosciences has 8 total employees.
-
What industry is Arcadia Biosciences in?
Arcadia Biosciences’s primary industry is Cultivation.
-
Is Arcadia Biosciences a private or public company?
Arcadia Biosciences is a Public company.
-
What is Arcadia Biosciences’s stock symbol?
The ticker symbol for Arcadia Biosciences is RKDA.
-
What is the current stock price of Arcadia Biosciences?
As of 18-Nov-2026 the stock price of Arcadia Biosciences is $0.19.
-
What is the current market cap of Arcadia Biosciences?
The current market capitalization of Arcadia Biosciences is $1.14M.
-
What is Arcadia Biosciences’s current revenue?
The trailing twelve month revenue for Arcadia Biosciences is $5.06M.
-
Who are Arcadia Biosciences’s competitors?
Archer Daniels Midland, Keygene, and Amyris (Biotechnology) are competitors of Arcadia Biosciences.
-
What is Arcadia Biosciences’s annual earnings per share (EPS)?
Arcadia Biosciences’s EPS for 12 months was -$3.37.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process